Phreesia Inc

Phreesia Inc

PHR

Get informed when a big investor buys or sells

+ Follow
Market Cap$751.01M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Phreesia IncPhreesia Inc79.8--3%1.40.4
$12.17

Target Price by Analysts

9.6% upsidePhreesia Target Price DetailsTarget Price
$29.73

Current Fair Value

167.8% upside

Undervalued by 167.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$751.01 Million
Enterprise Value$808.43 Million
Dividend Yield$- (-)
Earnings per Share$0.04
Beta0.84
Outstanding Shares60,944,962

Return

Return on Equity-2.73%ROE
Return on Assets-1.47%
Return on Invested Capital-0.18%

Valuation & Multiples

P/E Ratio79.83P/E Ratio
PEG-30.05PEG
Price to Sales1.39Price to Sales
Price to Book Ratio2.22Price to Book Ratio
Enterprise Value to Revenue1.63
Enterprise Value to EBIT-891.32
Enterprise Value to Net Income-83
Total Debt to Enterprise0.16
Debt to Equity0.37Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 3, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$129.06 M
Average shareholder expectation

Next Earnings Call

Expected Date
December 14, 2026
EPS Estimate
$0.12
Average shareholder expectation
Revenue Estimate
$128.37 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2916 317.68%
Total Calls402,600 389.78%
Total Puts117,400 58.82%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %97.31% 0.97%
Total Invested$657.12M 32.61%
Investors Holding235 18.00%

ESG Score

No data

About Phreesia Inc

CEO: Chaim Indig

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...